Abstract |
|
Authors | Gunnar Johansson, Yonatan Y Mahller, Margaret H Collins, Mi-Ok Kim, Takahiro Nobukuni, John Perentesis, Timothy P Cripe, Heidi A Lane, Sara C Kozma, George Thomas, Nancy Ratner |
Journal | Molecular cancer therapeutics
(Mol Cancer Ther)
Vol. 7
Issue 5
Pg. 1237-45
(May 2008)
ISSN: 1535-7163 [Print] United States |
PMID | 18483311
(Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Immunosuppressive Agents
- Quinazolines
- Everolimus
- Erlotinib Hydrochloride
- Protein Kinases
- MTOR protein, human
- mTOR protein, mouse
- Ribosomal Protein S6 Kinases, 70-kDa
- TOR Serine-Threonine Kinases
- ribosomal protein S6 kinase, 70kD, polypeptide 2
- Sirolimus
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Cell Death
- Cell Line, Tumor
- Drug Screening Assays, Antitumor
- Erlotinib Hydrochloride
- Everolimus
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Mice
- Mice, Nude
- Nerve Sheath Neoplasms
(drug therapy, metabolism)
- Protein Kinases
(metabolism)
- Quinazolines
(pharmacology)
- Ribosomal Protein S6 Kinases, 70-kDa
(metabolism)
- Signal Transduction
- Sirolimus
(analogs & derivatives, therapeutic use)
- TOR Serine-Threonine Kinases
- Up-Regulation
|